CJC 1295 DAC oral products are not effective: the peptide breaks down in digestion and no oral form is FDA-approved. Here's what research shows.
CJC-1295 DAC is not orally active. The peptide is destroyed by stomach acid and digestive enzymes before it can reach the bloodstream, and no oral version of this compound has been approved for human use in the United States. Products sold online as an oral CJC-1295 supplement are unregulated and often contain little or no detectable peptide.
What CJC-1295 DAC Actually Is
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone (GHRH), the natural signal your pituitary gland uses to trigger growth hormone release. The "DAC" stands for Drug Affinity Complex, a chemical tag added to the molecule so it binds to albumin in the blood.
That albumin binding is the entire point of the DAC modification. It slows clearance dramatically, which in early clinical research extended the peptide's half-life to roughly 6 to 8 days in humans. Unmodified GHRH is cleared in minutes.
In laboratory and phase I research, CJC-1295 DAC raised growth hormone and IGF-1 levels in test subjects. CJC-1295 is not FDA-approved for human use, and no regulatory agency anywhere has cleared an oral dosage form of it.
Why Oral CJC-1295 DAC Doesn't Survive Digestion
Peptides are fragile molecules. A chain of amino acids that works when injected is usually torn apart the moment it enters the digestive tract.
- Stomach acid: The acidic environment of the stomach unfolds and degrades peptide structure.
- Proteolytic enzymes: Pepsin and pancreatic proteases clip the peptide into inactive fragments.
- Poor permeability: At roughly 3.6 kDa, CJC-1295 is far larger than the ~500 Dalton ceiling for efficient passive absorption through the gut wall.
- First-pass metabolism: Anything that does cross the intestinal lining is filtered and broken down by the liver before reaching circulation.
Swallowing a peptide is therefore very different from injecting one. Oral bioavailability for molecules this size is generally well under 1%, which is why no pharmaceutical company has pursued an oral CJC-1295 product.
| Route | Peptide Reaches Bloodstream? | Half-Life | Notes |
|---|---|---|---|
| Oral (capsule, tablet) | Negligible | N/A | Destroyed by acid and enzymes |
| Sublingual drops | Unproven | N/A | Too large to cross oral mucosa efficiently |
| Nasal spray | Very low and inconsistent | Minutes | No oral or nasal product is approved |
| Subcutaneous injection | Yes | ~6–8 days (DAC) | The only route studied in humans |
CJC-1295 DAC vs No DAC: Why the Distinction Matters
People asking about cjc-1295 dac vs no dac are usually comparing two versions of the same peptide with very different behavior. The DAC version binds albumin and lasts for days. The version without DAC, sometimes labeled MOD GRF(1-29), is cleared in a matter of minutes and is normally paired with a separate peptide.
Neither version works orally. The DAC tag does not protect a peptide from digestion; it only extends how long the intact molecule circulates once it is already in the blood.
| Feature | CJC-1295 with DAC | CJC-1295 without DAC |
|---|---|---|
| Half-life | About 6–8 days | About 30 minutes |
| Albumin binding | Yes | No |
| Typical research frequency | Once weekly | 1–3 times daily |
| Common research pairing | Used alone | Stacked with ipamorelin |
| Orally active | No | No |
What Research Protocols Report About Dosing
Dosing information for CJC-1295 comes from research settings and online forums, not from approved prescribing guidelines. Published and community-documented material describes cjc-1295 with dac dosage in the range of roughly 1 to 2 mg per week, usually given as a single subcutaneous injection. Anyone wondering how much cjc 1295 with dac should i take needs to understand that every number circulating online is unverified and was never validated in a controlled human trial.
For the shorter-acting molecule, cjc-1295 no dac dosage is typically discussed as 100 mcg per injection, one to three times per day, frequently combined with a ghrelin-receptor agonist such as ipamorelin. That combination is a common topic in cjc 1295 no dac ipamorelin reddit threads, but forum anecdotes are not clinical evidence.
None of these protocols are FDA-reviewed, and none of them involve an oral product. A dosing schedule designed for an injection has no relationship to how much peptide a capsule would deliver.
What "Oral CJC-1295" Products Actually Contain
Capsules, sublingual drops, and oral sprays marketed as CJC-1295 are widely sold on supplement and gray-market websites. Independent testing of similar peptide products has repeatedly found that a large share contain no detectable active ingredient, incorrect amounts, or unrelated compounds.
Sellers often list cjc 1295 dac for sale alongside bulk cjc 1295 dac 5mg vials labeled "for research use only." That label is a legal disclaimer, not a quality guarantee. Once a vendor markets the same product for human consumption, it crosses into territory the FDA has repeatedly acted against through warning letters.
If a capsule genuinely contained a biologically active dose of CJC-1295, it would be a drug rather than a supplement, and it would require FDA approval that does not exist.
Safety, Legal Status, and Realistic Expectations
CJC-1295 is an unapproved investigational peptide in the United States. It is not a dietary supplement ingredient, and it cannot legally be sold as one.
Reported effects in early research included injection site reactions, flushing, headache, and water retention. Because CJC-1295 raises IGF-1, researchers have also flagged questions about blood sugar regulation, cardiovascular effects, and long-term risk from sustained growth hormone elevation. Long-term safety data in healthy adults do not exist.
An oral CJC-1295 product carries an added problem: even if the peptide survived digestion, no oral formulation has been tested for absorption, dosing accuracy, or contaminants. That makes the risk profile completely unknown.
Anyone considering any form of CJC-1295 should talk with a licensed healthcare professional first. People with a history of cancer, diabetes, or pituitary disorders face particular concerns because of how growth hormone and IGF-1 interact with those conditions.
The Bottom Line
There is no credible evidence that CJC-1295 DAC works when swallowed. The peptide degrades in the digestive tract, no oral formulation has been approved or clinically tested, and products marketed as oral CJC-1295 are unregulated. Subcutaneous injection is the only route that has been studied in humans, and even that remains investigational.
Frequently Asked Questions
Can you take CJC-1295 DAC orally?
No. CJC-1295 DAC is a peptide that is broken down by stomach acid and digestive enzymes, so very little if any intact peptide reaches the bloodstream when swallowed. No oral CJC-1295 product has been FDA-approved or tested in human trials. Subcutaneous injection is the only route that has been studied.
Is CJC-1295 DAC legal in the United States?
CJC-1295 is not FDA-approved for human use and is not a legal dietary supplement ingredient. It is sold online as a research chemical, usually labeled "for research use only," which does not make it legal to market for human consumption. The FDA has sent warning letters to vendors that cross that line.
How long does CJC-1295 DAC stay in your system?
The DAC version binds to albumin in the blood and has a half-life of roughly 6 to 8 days in humans according to early research. That means detectable levels can persist for several weeks after a single injection. Individual clearance varies, and no oral form has been measured.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.